Mass photometry’s unique bioanalytical workflow capabilities recognized by the scientific community, with over 500 scientific publications in just six years Sample loading on a Refeyn Mass Photometer Oxford, UK – Refeyn, the company behind pioneering mass photometry technologies, announces that it has established a new Scientific Advisory Board, chaired by Justin Benesch, Professor of Biophysical Chemistry, […]
Parting and future CEO of abberior instruments: Dr. Gerald Donnert (top) und Dr. Thorsten Staudt Göttingen, Germany — abberior instruments GmbH CEO Dr. Gerald Donnert will hand over his position to Dr. Thorsten Staudt on January 1, 2025. “I am delighted to be returning to microscopy, to further develop abberior instruments as a team and to […]
PISCATAWAY, N.J. — GenScript Biotech Corporation (“GenScript”), a global leader in life sciences products and services, announced the appointment of Dr. Ross Allen Grossman as a Non-Executive Director and Dr. Alphonse Galdes as an Independent Non-Executive Director. These appointments not only further diversify the Group’s Board but also highlight GenScript’s commitment to building an international, diverse, and highly specialized corporate […]
FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Chief Operating Officer, Chris Williams, will resign his position effective September 27, 2024, to accept a CEO position at another company. Cytek has chosen not to replace the COO position, opting instead to restructure the organization to […]
Appointment of leading technology innovator supports continued commercial development and R&D expansion Previously Senior Executive at Illumina, Co-Founder and former CEO of Helixis and Luxtera Cambridge, UK: Sphere Fluidics, a leading provider of innovative microfluidics-based solutions for single-cell analysis and isolation, today announced the appointment of Dr. Alex Dickinson to its Board of Directors as a […]
The clarification is that it is the nomination committee of Nanologica AB that has presented the proposal to elect Alexandra Blomberg Montgomery to the board of directors of Nanologica AB. The nomination committee, consisting of Carl-Johan Spak (Flerie Invest AB), Lennart Francke (Swedbank Robur funds), and Kalle Olby (Vega Bianca AB), has in connection with […]
Qkine is delighted to announce the appointment of Rob Nixon to its leadership team as Commercial Director and Paul Grafham as Chief Financial Officer. With years of experience working with fast-growing biotechs and life science reagent suppliers, these appointments will support the execution of the company’s growth strategies and expansion of its commercial operations globally. […]
CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, today announced a $13.5 million seed extension financing and the appointment of Sameer Rohatgi of LYFE Capital to their Board of Directors. The Series Seed 2 round was led by new investor, LYFE Capital, and existing investor Anzu Partners. New investors including Legend Star, RIT Venture Fund (Rochester […]
Accomplished R&D Leader and CRISPR Tools Expert Joins VedaBio to Drive Platform Expansion and Industrialization SAN DIEGO — VedaBio, a biotechnology company leading a paradigm shift in molecular detection, today announced the appointment of G. Brett Robb, Ph.D., as Senior Scientific Director and Head of CRISPR Science. With over 16 years of experience in life […]
Succeeds Dr. Stephen Schwartz Following 14-Year Tenure BURLINGTON, Mass. — Azenta, Inc. (Nasdaq: AZTA) (“Azenta” or “the Company”), today announced that John P. Marotta will join the Company as President and CEO effective September 9, 2024, succeeding Dr. Stephen Schwartz, who is retiring following a distinguished tenure. Dr. Schwartz will remain as an advisor to Azenta to ensure a smooth […]
Pay Invoice
Latest Blogs
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
